NCT00167648View on ClinicalTrials.gov

Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
CancerProstate Neoplasms
Interventions
DRUG

Leuprolide or goserelin

Leuprolide 7.5 mg (4-week depot) or goserelin 3.6 mg (4-week depot)

DRUG

Transdermal estradiol

Estradiol patches, six at 0.1 mg each, changed every 3-4 days

Trial Locations (2)

98119

VA Puget Sound Health Care System, Seattle

98195-6158

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

Pacific Northwest SPORE

OTHER

lead

University of Washington

OTHER

NCT00167648 - Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer | Biotech Hunter | Biotech Hunter